Location: Shanghai, China
Date:
Event description: CHINATRIALS 2025 brings together global and regional leaders shaping the future of clinical research and biotech innovation, spanning early pipeline strategy, cross-border clinical development, and strategic partnerships. As a leading Asia-Pacific CRO and trusted global partner, Novotech will participate in two sessions on 13 November: Novotech Participation (13 November): Moderator: Helen Jiang, Chief Medical Officer, Shanghai Best-Link Bioscience Panelists: Jian Zhang, Director of Medical Oncology, Fudan University Shanghai Cancer Center; Anwen Xiong, Associate Chief Physician & Associate Professor, Shanghai East Hospital; Shuhang Wang, Associate Chief Physician, Cancer Hospital Chinese Academy of Sciences; Jing Li, Vice President, Mabpharm; Yun Tian, Director of Medical Service and Strategy, Novotech. Moderator: Irene Hong, Founding Partner, CEC Capital Panelists: Anna French, Managing Partner, Qiming US; Andy Liu, General Manager, Novotech. If you’d like to connect with our team in Shanghai, please schedule a meeting via the form on this page.